Charles Vogel

565 total citations
14 papers, 243 citations indexed

About

Charles Vogel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Charles Vogel has authored 14 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in Charles Vogel's work include Cancer Treatment and Pharmacology (8 papers), Estrogen and related hormone effects (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Charles Vogel is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Estrogen and related hormone effects (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Charles Vogel collaborates with scholars based in United States, Australia and United Kingdom. Charles Vogel's co-authors include Joseph Bigley, John Hohneker, Laura F. Hutchins, Barbara Weber, Harry Harvey, Stephen E. Jones, Lee S. Schwartzberg, May Mo, Jorge Sierra and Stephanie A. Gregory and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Charles Vogel

14 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Vogel United States 5 211 80 46 37 24 14 243
Maria Giuseppa Sarobba Italy 10 194 0.9× 147 1.8× 13 0.3× 102 2.8× 63 2.6× 18 344
Johanna Sjöström Finland 6 227 1.1× 111 1.4× 10 0.2× 52 1.4× 16 0.7× 7 327
Tanja Badovinac Črnjević Switzerland 9 238 1.1× 64 0.8× 7 0.2× 106 2.9× 27 1.1× 16 326
Piergiorgio Giannessi Italy 6 167 0.8× 145 1.8× 6 0.1× 43 1.2× 21 0.9× 11 221
HJ Burstein United States 8 188 0.9× 84 1.1× 2 0.0× 61 1.6× 19 0.8× 25 223
Rodrigo Gonçalves Brazil 11 136 0.6× 190 2.4× 17 0.4× 69 1.9× 57 2.4× 29 321
Paul Swanson United States 7 212 1.0× 37 0.5× 5 0.1× 98 2.6× 16 0.7× 9 334
Bharani Dharan United States 6 144 0.7× 59 0.7× 5 0.1× 120 3.2× 11 0.5× 10 324
Phuong Dinh Australia 7 86 0.4× 36 0.5× 7 0.2× 21 0.6× 7 0.3× 8 166
Chunfang Hao China 11 108 0.5× 80 1.0× 5 0.1× 58 1.6× 21 0.9× 35 286

Countries citing papers authored by Charles Vogel

Since Specialization
Citations

This map shows the geographic impact of Charles Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Vogel more than expected).

Fields of papers citing papers by Charles Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Vogel. The network helps show where Charles Vogel may publish in the future.

Co-authorship network of co-authors of Charles Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Vogel. A scholar is included among the top collaborators of Charles Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Vogel. Charles Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Buzdar, Aman U., Charles Vogel, Lee Schwartzberg, et al.. (2011). Randomized double‐blind phase 2 trial of 3 doses of TAS‐108 in patients with advanced or metastatic postmenopausal breast cancer. Cancer. 118(13). 3244–3253. 4 indexed citations
2.
Vogel, Charles, et al.. (2010). Management of ErbB2-positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib. Japanese Journal of Clinical Oncology. 40(11). 999–1013. 19 indexed citations
3.
Gregory, Stephanie A., Lee S. Schwartzberg, May Mo, Jorge Sierra, & Charles Vogel. (2010). Evaluation of reported bone pain in cancer patients receiving chemotherapy in pegf lgrastim clinical trials: a retrospective analysis. Community Oncology. 7(7). 297–308. 26 indexed citations
4.
Schwartzberg, L., et al.. (2009). Reported Bone Pain in Patients with Breast Cancer Receiving Taxane-Based Chemotherapy in Clinical Trials of Pegfilgrastim.. Cancer Research. 69(24_Supplement). 1117–1117. 2 indexed citations
5.
Franco, Sandra, Alejandra Perez, Elizabeth Tan-Chiu, et al.. (2006). Updated results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC). Journal of Clinical Oncology. 24(18_suppl). 10685–10685. 3 indexed citations
6.
Franco, Sandra, Alejandra Perez, Elizabeth Tan-Chiu, et al.. (2005). Preliminary results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC). Journal of Clinical Oncology. 23(16_suppl). 876–876. 2 indexed citations
7.
Weber, Barbara, Charles Vogel, Stephen E. Jones, et al.. (1995). Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.. Journal of Clinical Oncology. 13(11). 2722–2730. 164 indexed citations
8.
Vogel, Charles, et al.. (1982). Sequential versus concomitant chemo-hormonal therapy in breast cancer. 2–7. 3 indexed citations
9.
Landgraf, H., et al.. (1981). [Effect of an infusion with middle molecular weight hydroxyethyl starch (HAES-steril 10%) on the flow properties of blood in healthy probands].. PubMed. 8(4). 200–4. 1 indexed citations
10.
Umsawasdi, Theera, Charles Vogel, & Wieland Voigt. (1981). Correlation between estrogen receptors and response to nonhormonal chemotherapy in metastatic breast cancer. 26–31. 2 indexed citations
11.
Vogel, Charles, Douglas S. Ross, & Christoph Kahl. (1981). Phase I clinical trial of weekly intravenous ICRF-187 (NSC 169780): A Southeastern Cancer Study Group trial. 1 indexed citations
12.
Vincent, R. G., Cyrus R. Mehta, Robert D. Tucker, et al.. (1980). Chemotherapy of extensive large cell and adenocarcinoma of the lung. A randomized trial in 210 patients. Cancer. 46(2). 256–260. 7 indexed citations
13.
Vogel, Charles, D. W. Paty, & Robert F. Kibler. (1972). Treatment of Experimental Allergic Encephalomyelitis in the Rabbit. Archives of Neurology. 26(4). 366–373. 4 indexed citations
14.
Vogel, Charles, Vincent T. De Vita, Robert P. Lisak, & M W Kies. (1969). Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative.. PubMed. 29(12). 2249–53. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026